CLR-300 series (Clera)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameCLR-300 series (Clera)
Drug Alias NameCLR-316CLR-302
ClassificationSmall molecules
Mechanisms of ActionSerotonin reuptake inhibitorsDopamine uptake inhibitors
TargetsSerotonin transporter
Therapy Area/IndicationsDepression
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesClera Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesClera Inc
Active IndicationsN/A
Inactive IndicationsDepression

Other Information

ATC CodeN/A
Related LinksN/A